ITS
InsiderTrading
TradesInsidersCompaniesCluster BuysRankingsAbout
ITS
InsiderTrading Screener

Track SEC Form 4 insider trades. See what corporate insiders are buying and selling.

Browse

  • Trades
  • Insiders
  • Companies
  • Cluster Buys
  • Rankings

Top Insiders

  • Mark Zuckerberg
  • Elon Musk
  • Jamie Dimon
  • Satya Nadella
  • Lisa Su
  • Jensen Huang

Screeners

  • CEO & CFO Purchases
  • Director Purchases
  • Top Buys This Week
  • Top Sales This Week
  • 10b5-1 Trades
  • Buy/Sell Ratios
  • Politician Overlap
  • Sectors

Learn

  • Learn
  • What is a Form 4?
  • About & Methodology
  • What are Cluster Buys?
  • Top Insider Rankings
  • Contact Us
  • Privacy Policy
  • Terms of Use

Data

  • SEC EDGAR Form 4 ↗
  • CongressStock.com ↗
  • Track13F.com ↗
  • About the data
© 2026 InsiderTradingScreener.com. Data from SEC EDGAR Form 4 filings.For informational purposes only. Not financial advice.
Home/Insiders/Gingras Christopher Raymond

Gingras Christopher Raymond

Director

Director
Total trades
39
Bought (open market)
$0
Sold (open market)
$58K
Acquired (grants)
$114K
Tickers traded
1
Gingras Christopher Raymond’s SEC Form 4 activity over the past year is confined entirely to a single issuer, MDV, and reveals a pattern that is overwhelmingly non-discretionary. Across 37 filings, there are no open-market purchases (code P) and no open-market sales (code S), leaving a total buy value and sell value of zero. Instead, the insider’s reported transactions consist of recurring monthly events coded as “J” — a designation typically reflecting an automatic dividend reinvestment or similar plan adjustment — alongside quarterly grants coded as “A,” which are compensation awards rather than conviction buys. The cumulative value of all acquisitions, including these mechanical and compensatory events, stands at $114,071.53, but the absence of any P or S codes signals that Gingras is not actively timing the market in MDV shares. The recent trade stream reinforces this passive posture. Between September 2025 and May 2026, Gingras filed roughly two dozen “J” transactions on MDV, each valued between roughly $500 and $1,100, with dates clustering on the 13th, 14th, or 15th of each month — a cadence consistent with scheduled plan contributions rather than ad hoc decisions. Interspersed are three “A” grants of $15,000 each on September 30, 2025, December 31, 2025, and March 31, 2026, which are standard quarterly equity awards. The most recent filings, dated May 15, 2026, show a modest $544.40 “J” transaction, continuing the established rhythm. Notably, there are no recent buy or sell counts, no option exercises (code M), and no tax-withholding events (code F) in the visible window, suggesting a clean, low-activity profile focused on accumulation through non-market mechanisms. What the data does not show is any directional bet. The insider has not added shares through open-market purchases, nor has he reduced his position through sales, gifts, or issuer buybacks. The $114,071.53 in total acquired value is almost entirely attributable to the recurring “J” credits and quarterly “A” grants, which are contractual or plan-driven rather than reflective of a bullish or bearish stance on MDV’s prospects. For investors monitoring insider behavior, Gingras’s filings offer little signal beyond steady, scheduled accumulation — a pattern that suggests compliance with a pre-arranged program rather than any reaction to company performance or market conditions.

AI-assisted summary

Recent trades

Most recent Form 4 filings by Gingras Christopher Raymond.

  • Gingras Christopher Raymondtraded2,292.399 shares ofMDVat $25.215$58KAug 12Details
  • Gingras Christopher Raymondtraded12,938.126 shares ofMDVAug 12Details
  • Gingras Christopher Raymondtraded29.962 shares ofMDVat $18.17$544May 15Details
  • Gingras Christopher Raymond

Explore insider screeners

Latest CEO & CFO PurchasesLatest CEO & CFO SalesDirector PurchasesOfficer PurchasesTop Purchases This WeekTop Sales This WeekTop Officer Buys (Month)10% Owner Filings10b5-1 Planned TradesDiscretionary TradesBuy/Sell RatiosPolitician-Insider Overlap
traded
43.05 shares of
MDV
at $24.97
$1KApr 15Details
  • Gingras Christopher Raymondtraded34.558 shares ofMDVat $15.65$541Apr 15Details
  • Gingras Christopher Raymondgranted1,047.486 shares ofMDVat $14.32$15KMar 31 · filed Apr 1Details
  • Gingras Christopher Raymondtraded36.763 shares ofMDVat $14.61$537Mar 13 · filed Mar 16Details
  • Gingras Christopher Raymondtraded37 shares ofMDVat $14.61$537Mar 13 · filed Mar 16Details
  • Gingras Christopher Raymondtraded44.745 shares ofMDVat $14.24$637Feb 13 · filed Feb 17Details
  • Gingras Christopher Raymondtraded45 shares ofMDVat $14.24$637Feb 13 · filed Feb 17Details
  • Gingras Christopher Raymondtraded35 shares ofMDVat $15.04$534Feb 13 · filed Feb 17Details
  • Gingras Christopher Raymondtraded35.473 shares ofMDVat $15.04$534Feb 13 · filed Feb 17Details
  • Gingras Christopher Raymondtraded34.824 shares ofMDVat $14.84$517Jan 15 · filed Jan 20Details
  • Gingras Christopher Raymondtraded45.03 shares ofMDVat $13.7$617Jan 15 · filed Jan 20Details
  • Gingras Christopher Raymondtraded35 shares ofMDVat $14.84$517Jan 15 · filed Jan 20Details
  • Gingras Christopher Raymondtraded45 shares ofMDVat $13.7$617Jan 15 · filed Jan 20Details
  • Gingras Christopher Raymondgranted1,042.391 shares ofMDVat $14.39$15KDec 31, 2025 · filed Jan 2Details
  • Gingras Christopher Raymondgranted1,042 shares ofMDVat $14.39$15KDec 31, 2025 · filed Jan 2Details
  • Gingras Christopher Raymondtraded37 shares ofMDVat $13.91$512Dec 15, 2025Details
  • Gingras Christopher Raymondtraded34 shares ofMDVat $14.89$514Dec 15, 2025Details
  • View all 39 trades →